UNC-School of Medicine: How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
February 28, 2024
February 28, 2024
CHAPEL HILL, North Carolina, Feb. 28 (TNSres) -- The University of North Carolina School of Medicine issued the following news release:
The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)--the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.
. . .
The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)--the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.
. . .